Jan M Vrolijk
Overview
Explore the profile of Jan M Vrolijk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
267
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Koggel L, Wahab P, Robijn R, Aufenacker T, Witteman B, Groenen M, et al.
Obes Surg
. 2020 Aug;
31(3):987-993.
PMID: 32829445
Purpose: Laparoscopy-assisted transgastric endoscopic retrograde cholangiopancreatography (LAERCP) is an alternative for the anatomically challenging conventional ERCP in patients with a Roux-en-Y gastric bypass (RYGB) as it allows access to the...
2.
van den Brand F, van der Veen K, Lissenberg-Witte B, de Boer Y, van Hoek B, Drenth J, et al.
Aliment Pharmacol Ther
. 2019 Oct;
50(10):1120-1126.
PMID: 31617229
Background: Autoimmune hepatitis requires long-term therapy, and systemic corticosteroids are the backbone of therapeutic management. Prolonged use of corticosteroids may lead to adverse events but data from long-term studies are...
3.
Lieveld F, Smit C, Richter C, van Erpecum K, Spanier B, Gisolf E, et al.
Liver Int
. 2018 Nov;
39(3):470-483.
PMID: 30411848
Background & Aims: HIV/hepatitis B virus (HBV) coinfected subjects are thought to have faster progression to end-stage liver disease (ESLD) than HBV mono-infected subjects. We assessed whether this remains in...
4.
van den Brand F, van der Veen K, de Boer Y, van Gerven N, Lissenberg-Witte B, Beuers U, et al.
Clin Gastroenterol Hepatol
. 2018 Oct;
17(5):940-947.e2.
PMID: 30291909
Background & Aims: There have been few reproducible studies of mortality in patients with autoimmune hepatitis (AIH) and its variants. We calculated mortality in a large national cohort of patients...
5.
van den Brand F, van Nieuwkerk C, Verwer B, de Boer Y, de Boer N, Mulder C, et al.
Aliment Pharmacol Ther
. 2018 Aug;
48(7):761-767.
PMID: 30109891
Background: Azathioprine (AZA) and mercaptopurine (MP) are the cornerstone of steroid-sparing strategies in autoimmune hepatitis (AIH). Up to 20% of patients do not tolerate or respond to these regimens. Aim:...
6.
Lieveld F, Arends J, Amelung L, Dijk E, Gisolf E, Vrolijk J, et al.
Clin Infect Dis
. 2016 Dec;
64(2):233-235.
PMID: 27989987
No abstract available.
7.
Coenen S, van Meer S, Vrolijk J, Richter C, van Erpecum K, Mostert M, et al.
Liver Int
. 2016 Mar;
36(10):1425-32.
PMID: 27001619
Background & Aims: In low-endemic countries it is debated whether first-generation migrants should be screened for chronic hepatitis B infection. We describe the clinical impact of five large-scale Dutch screening...
8.
de Boer Y, Gerven N, Zwiers A, Verwer B, van Hoek B, van Erpecum K, et al.
Gastroenterology
. 2014 Apr;
147(2):443-52.e5.
PMID: 24768677
Background & Aims: Autoimmune hepatitis (AIH) is an uncommon autoimmune liver disease of unknown etiology. We used a genome-wide approach to identify genetic variants that predispose individuals to AIH. Methods:...
9.
Gerven N, de Boer Y, Zwiers A, van Hoek B, van Erpecum K, Beuers U, et al.
Liver Int
. 2013 Apr;
33(7):1039-43.
PMID: 23551963
Background & Aims: Single nucleotide polymorphisms (SNP) in the Cytotoxic T lymphocyte antigen-4 gene (CTLA-4) have been associated with several autoimmune diseases including autoimmune Hepatitis (AIH). In this chronic idiopathic...
10.
Vrolijk J, van Noord D, Verhagen H, Pattynama P, Mensink P
Gastrointest Endosc
. 2010 Mar;
72(1):211-3.
PMID: 20227690
No abstract available.